Exhibit 1022 ยท Annual report
RELX Annual Report 2025, Market segments (Scientific, Technical & Medical)
In 2025, Elsevier received more than 4.2m article submissions, which were rigorously reviewed by our in-house editorial teams in collaboration with over 37,000 editors and over 1.9m expert reviewers around the world.
RELX reports Scientific, Technical & Medical (Elsevier) 2025 revenue of GBP 2,714m and adjusted operating profit of GBP 1,035m (a 38.1% ratio, computed here from the two printed figures; adjusted profit is RELX's own non-GAAP measure). The report states that the latest available long-term comparison showed Elsevier journal articles accounted for over 18% of global research output and 29% of citations, and that Elsevier published over 795,000 articles in 2025 after more than 4.2m submissions, with over 37,000 editors and over 1.9m reviewers. It does not state how many submissions were rejected.
- Source
- RELX PLC
- Date
- 2025 financial year (annual report published 2026)
- Quoted from
- Scientific, Technical & Medical section, p. 17 (corporate responsibility paragraph on peer review); 18% / 29% sentence p. 18; segment table (revenue 2,714; adjusted operating profit 1,035) p. 19 (printed page numbers)
- Grade
- Primary record
- Document
- https://www.relx.com/~/media/Files/R/RELX-Group/documents/reports/annual-reports/2025-ar-sections/relx-2025-market-segments.pdf
- Accessed
- 2026-11-10
- Cited by
- Findings citing this exhibit